ASK REDCHAT ANYTHING ABOUT CYCLERION THERAPEUTICS INC.
Cyclerion Therapeutics Inc. (NASDAQ: CYCN)
Listen to this Section
$2.97
-0.0900
(
-2.94% )
13.6K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Zagociguat (CY6463)DetailsNeurological disorder, Alzheimer's disease, Dementia |
Phase 2 |
| Zagociguat (CY6463)DetailsCognitive Impairment Associated with Schizophrenia |
Phase 1b |
| Praliciguat (sGC stimulator)DetailsHeart disease |
Failed |
| OlinciguatDetailsSickle cell disease |
Failed |
| Zagociguat (CY6463)DetailsRare diseases, Mitochondrial disease, Rare genetic disease |
Failed |
Market Data
|
| Open |
$2.97 |
| Previous Close |
$3.06 |
| Volume |
13.6K |
| Market Cap |
$12.99M |
| Day Range |
$2.95 - $3.08 |
| 52 Week Range |
$1.03 - $8.48 |
| Shares Outstanding |
4.33M |
| Change % |
-2.94% |
| Net Change |
▼ -0.0900 |
| Insider Ownership |
-0.04% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2019 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
-185,857.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-08-07 |
Sale |
-55849.00 |
Graul Regina Margaret |
| 2024-01-26 |
Sale |
-50000.00 |
Graul Regina Margaret |
| 2024-01-26 |
Sale |
-15000.00 |
Hecht Peter M |
| 2023-12-04 |
Sale |
-20000.00 |
Hyman Steven |
| 2023-12-04 |
Sale |
-20000.00 |
DESOUZA ERROL B |
| 2023-12-04 |
Sale |
-20000.00 |
Hecht Peter M |
| 2023-12-04 |
Sale |
-5000.00 |
MCGUIRE TERRANCE |
| 2023-08-11 |
Sale |
-8.00 |
MCGUIRE TERRANCE |